You're reading the free version. Trader adds the live tape and alerts.
Start tracking
EWTX Award Disclosure
Koch Kevin · SEC Form 4 · Filed Aug 14, 2026
Award
Calculated transaction value
$0
Koch Kevin President And CEO
EWTX
Transaction date
Aug 12, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed 2 days later
EWTX daily price context
Close on/before transaction
$43.56
Aug 12, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 200,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001185829-26-000001
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$785.04K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Edgewise Therapeutics, Inc. EWTX | Sale | Aug 12, 2026 | $383.25K |
| Edgewise Therapeutics, Inc. EWTX Current | Award | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Sale | Aug 12, 2026 | $361.32K |
| Edgewise Therapeutics, Inc. EWTX | Sale | Aug 12, 2026 | $40.47K |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Aug 12, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Award | Aug 12, 2026 | $0 |